| Capture, release and culture of circulating tumor cells from pancreatic cancer patients using an enhanced mixing chip W Sheng, OO Ogunwobi, T Chen, J Zhang, TJ George, C Liu, ZH Fan Lab on a Chip 14 (1), 89-98, 2014 | 309 | 2014 |
| Racial/ethnic disparities in genomic sequencing DE Spratt, T Chan, L Waldron, C Speers, FY Feng, OO Ogunwobi, ... JAMA oncology 2 (8), 1070-1074, 2016 | 285 | 2016 |
| Leptin stimulates proliferation and inhibits apoptosis in Barrett’s esophageal adenocarcinoma cells by cyclooxygenase-2-dependent, prostaglandin-E2-mediated transactivation of … O Ogunwobi, G Mutungi, ILP Beales Endocrinology 147 (9), 4505-4516, 2006 | 220 | 2006 |
| Mechanisms of hepatocellular carcinoma progression OO Ogunwobi, T Harricharran, J Huaman, A Galuza, O Odumuwagun, ... World journal of gastroenterology 25 (19), 2279, 2019 | 198 | 2019 |
| Biomarkers in colorectal cancer: current research and future prospects OO Ogunwobi, F Mahmood, A Akingboye International journal of molecular sciences 21 (15), 5311, 2020 | 172 | 2020 |
| The anti-apoptotic and growth stimulatory actions of leptin in human colon cancer cells involves activation of JNK mitogen activated protein kinase, JAK2 and PI3 kinase/Akt OO Ogunwobi, ILP Beales International journal of colorectal disease 22, 401-409, 2007 | 167 | 2007 |
| Adiponectin stimulates proliferation and cytokine secretion in colonic epithelial cells OO Ogunwobi, ILP Beales Regulatory peptides 134 (2-3), 105-113, 2006 | 166 | 2006 |
| Statins inhibit proliferation and induce apoptosis in Barrett's esophageal adenocarcinoma cells OO Ogunwobi, ILP Beales Official journal of the American College of Gastroenterology| ACG 103 (4 …, 2008 | 157 | 2008 |
| Hepatocyte growth factor upregulation promotes carcinogenesis and epithelial-mesenchymal transition in hepatocellular carcinoma via Akt and COX-2 pathways OO Ogunwobi, C Liu Clinical & experimental metastasis 28, 721-731, 2011 | 148 | 2011 |
| Epigenetic upregulation of HGF and c-Met drives metastasis in hepatocellular carcinoma OO Ogunwobi, W Puszyk, HJ Dong, C Liu PloS one 8 (5), e63765, 2013 | 114 | 2013 |
| OPA1 downregulation is involved in sorafenib-induced apoptosis in hepatocellular carcinoma X Zhao, C Tian, WM Puszyk, OO Ogunwobi, M Cao, T Wang, R Cabrera, ... Laboratory investigation 93 (1), 8-19, 2013 | 109 | 2013 |
| Globular adiponectin, acting via adiponectin receptor-1, inhibits leptin-stimulated oesophageal adenocarcinoma cell proliferation OO Ogunwobi, ILP Beales Molecular and cellular endocrinology 285 (1-2), 43-50, 2008 | 107 | 2008 |
| miRNAs associated with prostate cancer risk and progression HN Luu, HY Lin, KD Sørensen, OO Ogunwobi, N Kumar, G Chornokur, ... BMC urology 17, 1-18, 2017 | 104 | 2017 |
| miR-1207-3p regulates the androgen receptor in prostate cancer via FNDC1/fibronectin DK Das, M Naidoo, A Ilboudo, JY Park, T Ali, K Krampis, BD Robinson, ... Experimental cell research 348 (2), 190-200, 2016 | 72 | 2016 |
| Intrahepatic cholangiocarcinoma progression: prognostic factors and basic mechanisms AE Sirica, CI Dumur, DJW Campbell, JA Almenara, OO Ogunwobi, ... Clinical Gastroenterology and Hepatology 7 (11), S68-S78, 2009 | 72 | 2009 |
| Leptin synergistically enhances the anti-apoptotic and growth-promoting effects of acid in OE33 oesophageal adenocarcinoma cells in culture ILP Beales, OO Ogunwobi Molecular and cellular endocrinology 274 (1-2), 60-68, 2007 | 70 | 2007 |
| Survivin inhibition is critical for Bcl-2 inhibitor-induced apoptosis in hepatocellular carcinoma cells X Zhao, OO Ogunwobi, C Liu PloS one 6 (8), e21980, 2011 | 69 | 2011 |
| Leptin stimulates the proliferation of human oesophageal adenocarcinoma cells via HB-EGF and TGFα mediated transactivation of the epidermal growth factor receptor OO Ogunwobi, ILP Beales British journal of biomedical science 65 (3), 121-127, 2008 | 67 | 2008 |
| Oncogenic role of PVT1 and therapeutic implications OT Onagoruwa, G Pal, C Ochu, OO Ogunwobi Frontiers in oncology 10, 17, 2020 | 65 | 2020 |
| PVT1 signaling is a mediator of cancer progression C Derderian, AT Orunmuyi, EO Olapade-Olaopa, OO Ogunwobi Frontiers in Oncology 9, 502, 2019 | 65 | 2019 |
